Related Experiment Video
Updated: Jul 27, 2025

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Chronic Tubercular Mediastinitis: A Rare Case Presentation With Subcutaneous Emphysema
Sumer S Choudhary1, Chetan R Khedkar2, Gaurang M Aurangabadkar3
1Respiratory Medicine, Datta Meghe Medical College and Shalinitai Meghe Hospital and Research Centre, Nagpur, IND.
This case study highlights an exceptionally rare instance of chronic mediastinitis caused by tuberculosis, presenting with a tracheal fistula and subcutaneous emphysema. Prompt anti-tubercular treatment led to successful fistula closure and symptom resolution.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Chronic mediastinitis is typically caused by fungal infections, malignancy, or sarcoidosis.
- Tuberculosis (TB) is a rare cause of chronic mediastinitis, and its association with tracheal fistula and subcutaneous emphysema is exceptionally uncommon.
Observation:
- A 35-year-old male with chronic alcoholism presented with cough, chest pain, weight loss, and fever.
- High-resolution Computed Tomography (HRCT) revealed pleural-based nodular lesions, ground-glass opacities, and two tracheal fistulas with subcutaneous emphysema extending to the abdomen.
- Video bronchoscopy and 3D virtual bronchoscopy confirmed the tracheal fistula.
Findings:
- Biopsy confirmed tuberculosis via positive acid-fast bacilli (AFB) stain, PCR, and tuberculin skin test.
- The patient was initiated on anti-tubercular therapy.
- Follow-up HRCT and bronchoscopy demonstrated fibrosing scarring and successful fistula closure after treatment.
Implications:
- This case underscores the importance of considering tuberculosis in the differential diagnosis of chronic mediastinitis, even with unusual presentations like tracheal fistulas.
- Early diagnosis and appropriate anti-tubercular treatment are crucial for favorable outcomes in such rare cases.
- The successful management highlights the efficacy of standard anti-TB regimens in complex thoracic infections.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

